Max Stanley Chartrand
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Angiogenesis and VEGF in Cancer 2
- Viral Infectious Diseases and Gene Expression in Insects 2
- Oncology 6
- CAR-T cell therapy research 6
- Co-authors
- Heshu Sulaiman Rahman (15 shared papers)Mostafa Jarahian (7 shared papers)Faroogh Marofi (7 shared papers)Farideh Namvar (5 shared papers)Swee Keong Yeap (6 shared papers)Navid Shomali (5 shared papers)Roza Motavalli (4 shared papers)Alexei Valerievich Yumashev (4 shared papers)
In The Last Decade
Max Stanley Chartrand
16 papers receiving 1.3k citations
Max Stanley Chartrand's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 487
- Immunology 291
- Pharmacology 87
- Biomaterials 104
- Molecular Medicine 35
Countries citing papers authored by Max Stanley Chartrand
This map shows the geographic impact of Max Stanley Chartrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Stanley Chartrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Stanley Chartrand more than expected).
Fields of papers citing papers by Max Stanley Chartrand
This network shows the impact of papers produced by Max Stanley Chartrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Stanley Chartrand. The network helps show where Max Stanley Chartrand may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Stanley Chartrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CAR T cells in solid tumors: challenges and opportunities Hit paper breakdown → | 2021 | 412 |
| 2 | 2014 | 211 | |
| 3 | 2021 | 148 | |
| 4 | 2015 | 119 | |
| 5 | 2021 | 106 | |
| 6 | 2021 | 86 | |
| 7 | 2014 | 75 | |
| 8 | 2021 | 38 | |
| 9 | 2015 | 28 | |
| 10 | 2021 | 19 | |
| 11 | 2015 | 15 | |
| 12 | 2020 | 11 | |
| 13 | 2014 | 10 | |
| 14 | 2021 | 4 | |
| 15 | The Effectiveness of Super Ovulation and Multiple Pregnancies in Sprague Dawley Rat using Morus alba Linn. Fruit | 2018 | 3 |
| 16 | 2018 | 2 |
About Max Stanley Chartrand
Max Stanley Chartrand is a scholar working on Molecular Biology, Oncology, Aquatic Science, Pharmacology and Plant Science, having authored 16 papers that have together received 1.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Ginger and Zingiberaceae research (3 papers), Seaweed-derived Bioactive Compounds (3 papers), Nanoparticles: synthesis and applications (2 papers), Phytochemistry and biological activity of medicinal plants (2 papers), Immune Cell Function and Interaction (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). The work is most often cited by research in Oncology (487 citations), Immunology (291 citations), Pharmacology (87 citations), Biomaterials (104 citations) and Molecular Medicine (35 citations). Max Stanley Chartrand has collaborated with scholars based in Iraq, Iran and Malaysia. Frequent co-authors include Heshu Sulaiman Rahman, Mostafa Jarahian, Faroogh Marofi, Farideh Namvar, Swee Keong Yeap, Navid Shomali, Roza Motavalli, Alexei Valerievich Yumashev, Yashwant Pathak and Safa Tahmasebi. Their work appears in journals such as Stem Cell Research & Therapy, BioMed Research International, Natural Product Communications, Evidence-based Complementary and Alternative Medicine and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.